Lauren A Hymel (L A Hymel, Lauren Hymel)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Antiplatelet Therapy

Systemic Sclerosis

Top Venues

Science advances

Journal of biomedical materials research. Part A

bioRxiv : the preprint server for biology

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Lauren A Hymel, Shannon E Anderson, Thomas C Turner, William Y York, Hongmanlin Zhang, Adrian R Liversage, Hong Seo Lim, Peng Qiu, Luke J Mortensen, Young Charles Jang, Nick J Willett, Edward A Botchwey
Identifying dysregulated immune cell subsets following volumetric muscle loss with pseudo-time trajectories. Communications biology 6 (1) (2023)
Afra I Toma, Daniel Shah, Daniela Marta Roth, Jeremie Oliver Piña, Lauren A Hymel, Thomas Turner, Archana Kamalakar, Ken Liu, Perry Bartsch, Leon Jacobs, Rena N D'Souza, Dennis Liotta, Edward A Botchwey, Nick J Willett, Steven L Goudy
Harnessing Bilayer Biomaterial Delivery of FTY720 as an Immunotherapy to Accelerate Oral Wound Healing. bioRxiv : the preprint server for biology (2023)
Marc A Fernandez-Yague, Lauren A Hymel, Claire E Olingy, Claire A McClain, Molly E Ogle, José R García, Dustin Minshew, Sofiya Vyshnya, Hong Seo Lim, Peng Qiu, Andres J Garcia, Edward A Botchwey
Analyzing immune response to engineered hydrogels by hierarchical clustering of inflammatory cell subsets. Science advances 8 (8) (2022)
Lauren A Hymel, Molly E Ogle, Shannon E Anderson, Cheryl L San Emeterio, Thomas C Turner, William Y York, Alan Y Liu, Claire E Olingy, Sraeyes Sridhar, Hong Seo Lim, Todd Sulchek, Peng Qiu, Young C Jang, Nick J Willett, Edward A Botchwey
Modulating local S1P receptor signaling as a regenerative immunotherapy after volumetric muscle loss injury. Journal of biomedical materials research. Part A 109 (5) (2020)
T C Turner, M C P Sok, Lauren A Hymel, F S Pittman, W Y York, Quoc D Mac, Sofiya Vyshnya, Hong Seo Lim, Gabriel A Kwong, Peng Qiu, Edward A Botchwey
Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy. Science advances 6 (44) (2020)